Increasing Viral Testing in the Emergency Department (InVITED)

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Roland C. Merchant, MD. MPH, ScD, Rhode Island Hospital
ClinicalTrials.gov Identifier:
NCT01419899
First received: July 6, 2011
Last updated: August 5, 2013
Last verified: August 2013

July 6, 2011
August 5, 2013
January 2011
January 2012   (final data collection date for primary outcome measure)
The agreement of the participant to be tested for HIV and hepatitis C [ Time Frame: Within four hours of being consented into the study ] [ Designated as safety issue: No ]
We will measure the acceptance of free rapid testing for HIV and hepatitis C among the intervention and control groups
Same as current
Complete list of historical versions of study NCT01419899 on ClinicalTrials.gov Archive Site
Identifying risky sexual behaviors of study participants [ Time Frame: Within four hours of being consented into the study ] [ Designated as safety issue: No ]
Identify factors that influence the relationship of BI and risk assessment vs. risk assessment alone on uptake of combined HIV and hepatitis C screening in the ED.
Same as current
Not Provided
Not Provided
 
Increasing Viral Testing in the Emergency Department
Phase 2/3 Clinical Trial of the Effect of a Brief Intervention on Uptake of Rapid Testing for HIV and Hepatitis C Among Emergency Department Patients

The purpose of this study is to determine if a brief intervention delivered to emergency department patients increases the uptake of rapid HIV and hepatitis C testing in comparison to no brief intervention.

Not Provided
Interventional
Phase 2
Phase 3
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Outcomes Assessor)
Primary Purpose: Prevention
  • Drug Use
  • HIV
  • Hepatitis C
Behavioral: Brief motivational intervention
A 20-30 minute motivational based discussion
  • Experimental: Brief Intervention
    This arm of the study will receive an assessments survey followed by a brief intervention concerning the relationship between the participants use of drugs and/or sexual risk and rik for HIV and hepatitis C infections. Following the intervention the participants will be offered free rapid testing for HIV and hepatitis C.
    Intervention: Behavioral: Brief motivational intervention
  • No Intervention: Standard Care
    This arm of the study will receive an assessments survey. Following the assessment the participants will be offered free rapid testing for HIV and hepatitis C.
Merchant RC, Baird JR, Liu T, Taylor LE. HCV among The Miriam Hospital and Rhode Island Hospital Adult ED Patients. R I Med J (2013). 2014 Jul 1;97(7):35-9.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
398
January 2012
January 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Emergency department patient.
  • Does not know HIV or hepatitis C status.
  • Has an ASSIST V3 score that indicates recent illicit and/or prescription drug use.
  • Fluency in English or Spanish.

Exclusion Criteria:

  • Critically ill or injured.
  • Homicidal and/or suicidal intention.
  • Age < 18 years or > 64 years.
  • Does not speak English or Spanish.
Both
18 Years to 64 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01419899
5R21DA28645-2
Yes
Roland C. Merchant, MD. MPH, ScD, Rhode Island Hospital
Rhode Island Hospital
National Institute on Drug Abuse (NIDA)
Principal Investigator: Roland C Merchant, MD, ScD Brown University
Principal Investigator: Ted D Nirenberg, PhD Brown University
Rhode Island Hospital
August 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP